T2 Biosystems(TTOO)
$0.010.00 (0.00%)
TTOO
T2 Biosystems financials statements
$0.01
At close:0.00 (0.00%)
Want to see TTOO full AI Analyst Report?
T2 Biosystems (TTOO) Ratios
2,236 Followers
T2 Biosystems Ratios
TTOO's free cash flow for Q3 2024 was $-6.25M. For the 2024 fiscal year, TTOO's free cash flow was increased by $0.00 and operating cash flow was $-6.25M. See a summary of the company’s cash flow.
| Ratios | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.45 | 1.92 | 3.80 | 5.47 | 0.31 |
| Quick Ratio | 0.36 | 1.49 | 3.46 | 5.10 | 0.25 |
| Cash Ratio | 0.28 | 1.02 | 1.90 | 1.71 | 0.18 |
| Solvency Ratio | -0.78 | -0.82 | -0.64 | -0.62 | -0.89 |
| Operating Cash Flow Ratio | -0.86 | -5.00 | -3.33 | -4.41 | -0.75 |
| Short-Term Operating Cash Flow Coverage | -1.17 | -37.45 | 0.00 | -37.55 | -1.06 |
| Net Current Asset Value | $ -37.64M | $ -54.94M | $ -29.05M | $ -16.77M | $ -43.60M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 1.42 | 1.72 | 0.96 | 0.72 | 1.57 |
| Debt-to-Equity Ratio | -1.77 | -1.48 | -4.52 | 6.52 | -1.32 |
| Debt-to-Capital Ratio | 2.31 | 3.08 | 1.28 | 0.87 | 4.16 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 5.13 | 1.37 | 0.84 | 0.00 |
| Financial Leverage Ratio | -1.24 | -0.86 | -4.69 | 9.06 | -0.84 |
| Debt Service Coverage Ratio | -0.94 | -7.38 | -5.41 | -5.52 | -0.96 |
| Interest Coverage Ratio | -9.30 | -8.88 | -5.66 | -7.51 | -7.08 |
| Debt to Market Cap | 2.52 | 7.04 | 0.58 | 0.31 | 0.81 |
| Interest Debt Per Share | 21.01 | 1280.34 | 2074.75 | 2572.45 | 5727.17 |
| Net Debt to EBITDA | -0.77 | -0.89 | -0.88 | -1.09 | -0.70 |
| Profitability Margins | |||||
| Gross Profit Margin | -113.58% | 5.23% | 26.21% | -17.37% | -101.12% |
| EBIT Margin | -621.91% | -250.70% | -155.62% | -219.88% | -623.17% |
| EBITDA Margin | -609.97% | -246.01% | -146.58% | -202.48% | -579.47% |
| Operating Profit Margin | -690.45% | -242.30% | -153.16% | -228.11% | -624.57% |
| Pretax Profit Margin | -696.19% | -277.98% | -175.50% | -258.12% | -707.93% |
| Net Profit Margin | -696.19% | -277.98% | -175.50% | -258.12% | -707.93% |
| Continuous Operations Profit Margin | -696.19% | -277.98% | -175.50% | -258.12% | -707.93% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 100.83% | 114.72% | 114.59% | 113.16% | 113.35% |
| Return on Assets (ROA) | -143.91% | -180.29% | -81.34% | -59.18% | -207.14% |
| Return on Equity (ROE) | 178.62% | 155.13% | 381.62% | -536.31% | 173.52% |
| Return on Capital Employed (ROCE) | 232.56% | -222.75% | -87.97% | -59.70% | 162.25% |
| Return on Invested Capital (ROIC) | -230.51% | -200.41% | -85.90% | -57.78% | -406.73% |
| Return on Tangible Assets | -143.91% | -180.29% | -81.34% | -59.18% | -207.14% |
| Earnings Yield | -305.52% | -856.11% | -60.07% | -31.11% | -110.83% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.07 | 10.31 | 5.47 | 3.56 | 2.95 |
| Payables Turnover | 10.06 | 16.31 | 7.31 | 10.34 | 4.47 |
| Inventory Turnover | 3.19 | 4.86 | 5.30 | 5.85 | 4.66 |
| Fixed Asset Turnover | 0.79 | 1.68 | 1.94 | 1.22 | 0.91 |
| Asset Turnover | 0.21 | 0.65 | 0.46 | 0.23 | 0.29 |
| Working Capital Turnover Ratio | -0.66 | 1.06 | 0.73 | 17.21 | -0.45 |
| Cash Conversion Cycle | 150.27 | 88.11 | 85.77 | 129.72 | 120.36 |
| Days of Sales Outstanding | 72.06 | 35.40 | 66.79 | 102.65 | 123.71 |
| Days of Inventory Outstanding | 114.49 | 75.09 | 68.92 | 62.37 | 78.37 |
| Days of Payables Outstanding | 36.28 | 22.38 | 49.93 | 35.30 | 81.72 |
| Operating Cycle | 186.55 | 110.49 | 135.70 | 165.02 | 202.08 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -18.44 | -992.67 | -1223.53 | -1780.89 | -4984.18 |
| Free Cash Flow Per Share | -18.52 | -999.31 | -1238.01 | -1814.02 | -5067.79 |
| Dividend Paid and CapEx Coverage Ratio | -250.71 | -149.35 | -84.51 | -53.75 | -59.61 |
| Capital Expenditure Coverage Ratio | -250.71 | -149.35 | -84.51 | -53.75 | -59.61 |
| Operating Cash Flow Coverage Ratio | -0.97 | -0.85 | -0.67 | -0.76 | -1.01 |
| Operating Cash Flow to Sales Ratio | -6.69 | -2.27 | -1.39 | -2.38 | -5.44 |
| Free Cash Flow Yield | -294.85% | -703.74% | -47.98% | -29.26% | -86.63% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.33 | -0.12 | -1.66 | -3.21 | -0.90 |
| Price-to-Sales (P/S) Ratio | 2.28 | 0.32 | 2.92 | 8.30 | 6.39 |
| Price-to-Book (P/B) Ratio | -0.58 | -0.18 | -6.35 | 17.24 | -1.57 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.34 | -0.14 | -2.08 | -3.42 | -1.15 |
| Price-to-Operating Cash Flow Ratio | -0.34 | -0.14 | -2.11 | -3.48 | -1.17 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | 0.01 | 0.08 | 0.04 | -0.00 |
| Enterprise Value Multiple | -1.14 | -1.02 | -2.87 | -5.19 | -1.80 |
| Enterprise Value | 50.20M | 56.13M | 118.05M | 190.58M | 86.98M |
| EV to EBITDA | -1.14 | -1.02 | -2.87 | -5.19 | -1.80 |
| EV to Sales | 6.98 | 2.52 | 4.21 | 10.51 | 10.44 |
| EV to Free Cash Flow | -1.04 | -1.10 | -3.00 | -4.33 | -1.89 |
| EV to Operating Cash Flow | -1.04 | -1.11 | -3.04 | -4.41 | -1.92 |
| Tangible Book Value Per Share | -10.74 | -783.66 | -406.11 | 359.60 | -3736.40 |
| Shareholders’ Equity Per Share | -10.74 | -783.66 | -406.11 | 359.60 | -3736.40 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 2.76 | 437.33 | 883.10 | 747.14 | 915.83 |
| Net Income Per Share | -19.19 | -1215.67 | -1549.82 | -1928.54 | -6483.46 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.12 | 1.11 | 1.13 | 1.17 | 1.14 |
| Research & Development to Revenue | 1.97 | 1.16 | 0.78 | 0.93 | 1.96 |
| SG&A to Revenue | 0.00 | 1.37 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.60 | 0.29 | 0.25 | 0.22 | 0.65 |
| Income Quality | 0.96 | 0.82 | 0.79 | 0.92 | 0.77 |
Currency in USD

